| Interim Healthcare Of Oklahoma City, Inc | |
| 3613 Nw 56th Street, Suite 385, Oklahoma City, Oklahoma 73112 | |
| (405) 848-3555 | |
| Name | Interim Healthcare Of Oklahoma City, Inc |
|---|---|
| Location | 3613 Nw 56th Street, Suite 385, Oklahoma City, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377658 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 73002, 73003, 73007, 73008, 73010, 73012, 73013, 73018, 73020, 73025, 73026, 73027, 73028, 73034, 73036, 73040, 73044, 73045, 73049, 73051, 73052, 73054, 73064, 73065, 73067, 73068, 73069, 73071, 73072, 73078, 73084, 73089, 73093, 73097, 73099, 73102, 73103, 73104, 73105, 73106, 73107, 73108, 73109, 73110, 73111, 73112, 73114, 73115, 73116, 73117, 73118, 73119, 73120, 73121, 73122, 73127, 73128, 73129, 73130, 73131, 73132, 73134, 73135, 73139, 73141, 73142, 73144, 73145, 73149, 73150, 73151, 73159, 73160, 73162, 73165, 73169, 73170, 73179, 74801, 74802, 74804, 74832, 74834, 74851, 74852, 74855, 74857, 74868, 74869, 74873, 74881 |
| NPI Number | 1720338932 |
| Organization Name | INTERIM HEALTHCARE OF OKLAHOMA CITY, INC. |
| Address | 5600 N May Ave, Suite 145, Oklahoma City, OK 73112 |
| Phone Number | 405-848-3555 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| NPI Number | 1821057134 |
| Organization Name | INTERIM HEALTHCARE OF OKLAHOMA CITY, INC |
| Address | 3613 Nw 56th St Ste 385, Oklahoma City, OK 73112 |
| Phone Number | 405-848-3555 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| NPI Number | 1881138626 |
| Organization Name | INTERIM HEALTHCARE OF OKLAHOMA CITY, INC |
| Address | 3613 Nw 56th St, Suite 385, Oklahoma City, OK 73112 |
| Phone Number | 405-848-3555 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| Quality Rating: |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 98.9 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98.1 | 99.6 |
| How often the home health team checked patients for depression | 97.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 88.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 92.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.7 | 96.4 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 89.4 | 79.6 |
| How often patients got better at getting in and out of bed | 79.7 | 81.1 |
| How often patients got better at bathing | 90.3 | 82.3 |
| How often patients’ breathing improved | 90.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 100 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 85.3 | 75 |
| How often home health patients had to be admitted to the hospital | 13 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98 | 94 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
The patient survey data of Interim Healthcare Of Oklahoma City, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 83 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 80 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 77 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 80 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 67 | 78 |
News Archive
The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.
Allied BioScience, a Plano, Texas-based biotechnology company announced today it has received an approved label from the U.S. Environmental Protection Agency for SurfaceWise, a new bacteriostatic surface coating that inhibits the growth of and provides continuous protection against bacteria, fungi and algae which cause odor, staining and discoloration in various commercial settings, including hospitals and sports facilities.
Roll Call reports that "labor unions representing federal employees are pressing for temporary health insurance coverage for college-age students who will otherwise be thrown off their parents' health insurance plans when they turn 22 years old." The new health law has a provision guaranteeing such access but that isn't scheduled to take effect for federal health beneficiaries until January, even though a number of private plans are moving to implement the coverage earlier.
A researcher from Dartmouth reports the results of a clinical trial that shows that the cyclooxygenase-2 (COX-2) inhibitor rofecoxib (VIOXX.) reduces the risk of colorectal adenomas, or polyps.
› Verified 3 days ago
Ssm Health At Home Home Health - Oklahoma Location: 608 Nw 9th Street, Suite 6200, Oklahoma City, Oklahoma 73103 Ratings: Phone: (405) 231-2992 | |
Mercy Home Health Location: 4401 W Memorial, Suite 143, Oklahoma City, Oklahoma 73134 Ratings: Phone: (405) 486-8600 | |
Integris Home Care Oklahoma City Location: 3500 N W 56th Street, Ste 201, Oklahoma City, Oklahoma 73112 Ratings: Phone: (405) 951-8400 | |
Alliance Oklahoma Home Health Okc Location: 7919 Mid America Blvd, Suite 200, Oklahoma City, Oklahoma 73135 Ratings: Phone: (405) 736-0064 | |
Angels Care Home Health Of Oklahoma Location: 4045 Nw 64th Street, Suite 150, Oklahoma City, Oklahoma 73116 Ratings: Phone: (405) 767-9555 | |
Carter Healthcare Of Central Oklahoma, Llc Location: 3104 South Lakeside Drive, Oklahoma City, Oklahoma 73119 Ratings: Phone: (405) 947-7700 |